GreinDX AS
Oslo, Norway
|
Main sector: |
|
Subsector: |
|
Indications: |
|
Description:
GreinDX AS develops a novel comprehensive Liquid Biopsy technology fplatform. The company aim to build a bench-top system that can capture and study viable Circulating Tumor Cells (CTCs), circulating Tumor DNA (ctDNA), Extracelluløar Vescicles (EVs), and circulating Tumor Antigens (CTA) from a single blood sample or from other body fluids. The bench-top system will includes a proprietasry silcicon disc with > 1 million microwells, a microfluidic system, and optical/ imaging system,...
GreinDX AS develops a novel comprehensive Liquid Biopsy technology fplatform. The company aim to build a bench-top system that can capture and study viable Circulating Tumor Cells (CTCs), circulating Tumor DNA (ctDNA), Extracelluløar Vescicles (EVs), and circulating Tumor Antigens (CTA) from a single blood sample or from other body fluids. The bench-top system will includes a proprietasry silcicon disc with > 1 million microwells, a microfluidic system, and optical/ imaging system,...